TG Therapeutics
TGTX
TGTX
360 hedge funds and large institutions have $3.5B invested in TG Therapeutics in 2026 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 135 increasing their positions, 104 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.01% more ownership
Funds ownership: 64.97% → 65.98% (+1%)
0% more call options, than puts
Call options by funds: $82.4M | Put options by funds: $82.3M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
360
Holding in Top 10
4
Calls
$82.4M
Puts
$82.3M
Top Buyers
| 1 | +$31.9M | |
| 2 | +$27.2M | |
| 3 | +$26.5M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$21.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$18.2M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$21.4M | |
| 3 | -$17.9M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$16.7M |
| 5 |
Millennium Management
New York
|
-$16.5M |
